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a b s t r a c t
To test the validity of the polymerase chain reaction for diagnosing American visceral leish-
maniasis, 88 suspected cases were studied. Diagnosis was conﬁrmed in 47 (53.5%) and ruled
out in 41 (46.5%) patients. Samples of bone marrow and peripheral blood were processed
by polymerase chain reaction to evaluate the sensitivity and speciﬁcity of the test and its
agreement beyond chance with microscopy examination. The polymerase chain reaction
was positive in bone marrow of 100% of the patients with amastigotes seen with microscopy
examination, and in 59.5% in those where no parasite were seen. Agreement beyond chance
between visualization of the parasite in bone marrow aspirates and polymerase chain reac-
tion was considered weak (Kappa=0.41). Concordance between polymerase chain reaction
of bone marrow aspirates and of peripheral blood was considered excellent (Kappa=0.88).one marrow blood The test turned out positive in all bone marrow aspirates of those with the disease and
whereas the positivity rate was 58.5% among those without the disease, with speciﬁcity
rate of 41.5%.
with conﬁrmed AVL diagnosis to healthy persons, ﬁtting Type
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linicians who work in areas where American visceral leish-
aniasis (AVL) is endemic are not always able to diagnose
he cases due to regional concurrence of other diseases with
imilar manifestations. Deﬁnitive diagnosis is made by the
dentiﬁcation of the parasites in tissue aspirates, either spleen
r bone marrow. Spleen aspirate yield higher percentage of
ositivity but, due to bleeding risks, the bone marrow aspirate
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Este é um artigo Open Access sob a licençais more frequently used, despite having lower sensitivity.1
Parasite identiﬁcation tests are invasive and uncomfortable,
require trained personnel and a negative result do not rule out
AVL diagnosis. Studies have shown polymerase chain reaction
(PCR) to be both highly speciﬁc and sensitive for the diagnosis
of visceral leishmaniasis.2–7 These studies compared people635, Brazil.
II Study Classiﬁcation of Sacket and Haynes.8 The purpose of
the present study was to test the validity of PCR in a group
of patients with clinical suspicion of AVL. The PCR protocol
 de CC BY-NC-ND
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Table 1 – Comparison of PCR and microscopy for
detection of Leishmania in bone marrow (Kappa=0.41).
PCR result Microscopy/parasite Total
Positive Negative
Positive 46 (100%) 25 (59.5%) 71
Negative 0 17 (40.5%) 17
Total 46 42 88
patients (cases) and in 24 (58.5%) of those who did not
have active disease, indicating low speciﬁcity, as observed in
Table 2.
Table 2 – PCR results in bone marrow aspirates of
patients with and without American visceral
leishmaniasis prior to treatment.
PCR result American visceral leishmaniasis 95% CI
Cases Non-cases
Positive 47 (100%) 24 (58.5%) 90.5–100.0
Negative – 17 (41.5%) 26.7–57.8320 braz j infect d
described by Smyth et al.9 was used in this study because, at
the time, it was the standard method for DNA sequencing of
regional Leishmania chagasi.
Materials and methods
The type of study carried out was the “diagnostic test vali-
dation”, corresponding to phase III of Sacket and Haynes8
classiﬁcation. The study included patients with diagnostic
hypothesis of AVL admitted to “Hospital Escola Dr. Hélvio
Auto” (HEHA), Maceió, Alagoas, between April 2003 and March
2005.
Study population
The “cases” consisted of persons originating from endemic
regions, with fever for 14 or more days, pallor, hep-
atosplenomegaly, and with or without amastigotes of
Leismania in bone marrow aspirate smears. For those with
negative bone marrow aspirate, the inclusion criteria was the
hematologic tests (pancytopenia) and favourable response to
treatment.10 Patients diagnosed as having AVL were treated
with meglumine antimoniate, except for those with intoler-
ance to the ﬁrst dose of the medication, who were switched to
amphotericin-B. Cure was deﬁned according to the following
criteria established by the BrazilianMinister of Health (2003)10:
resolution of fever, reduction of visceral size, hemoglobin
and leukocyte count elevation, weight gain. The “non-cases”,
although with some of the above-mentioned manifestations
of the disease, did not fulﬁll all diagnostic criteria. The
variables listed in the protocol were: sex, age, size of liver
and spleen, PCR result, and visualization of amastigotes in
bone marrow aspirate by microscopy.11 Informed consent was
obtained from patients or their representatives. Laboratory
tests were performed according to the protocol established by
the World Health Organization11 and adopted by the Brazilian
Ministry of Health.10
Laboratory examination
Samples of peripheral blood and bone marrow were collected
in tubes with EDTA, kept at −20 ◦C for future processing by
PCR ampliﬁcation. DNA was extracted from these samples
using the GFX genomic blood DNA puriﬁcation kit (Amersham
Pharmacia Biotech) according to manufacture’s instructions.
The used primers: AJS3 (5′-GGGGGTGGTAAATAGG-3′) and DB8
(5′-CCAGTTTCCCGCCCCG-3′), ampliﬁes a ∼800-base pairs (bp)
sequenceof a speciﬁc kinetoplastDNAminicircle of Leishmania
described elsewhere.9
PCR reactions were carried out in a total volume of 50L
of reaction mixture containing 4L of extracted DNA, 0.3M
of the primers AJS3 and DB8 (Invitrogen, USA), 1.25M of
each dNTP (Ludwig Biotecnologia Ltda), 3.0mM MgCl2 (Lud-
wig Biotecnologia Ltda), 2.5U/L Taq DNA Polymerase (Ludwig
Biotecnologia Ltda), and water free of nuclease (Promega,
Madison, WI, USA). The PCR conditions consisted of 3min
at 95 ◦C, followed by 35 cycles of denaturing at 95 ◦C for 30 s,
annealing at 60 ◦C for 30 s, extension at 72 ◦C for 30 s and a ﬁnal
extension for 6min at 72◦ C. PCR products were submittedPCR, polymerase chain reaction.
to electrophoresis in a 1.2% (w/v) agarose gel stained with
ethidium bromide (4.0mg/L) and identiﬁed by visualizing the
bands of expected size under UV transilluminator. A negative
extraction control was used to assure absence of contam-
ination during DNA extraction process. A negative control
containing distilled DNA free water was also used.
Data analysis
Sensitivity and speciﬁcity with the respective conﬁdence
intervals were estimated for PCR results using bone marrow
aspirate and peripheral blood in relation to tissue microscopy.
Concordance between PCR results in bonemarrowandperiph-
eral blood were assessed by Kappa statistic.12
Results
The study population consisted of 88 subjects, predominantly
males (60.2%), below the age of 15 (55.7%), and of rural origin
(64.8%). Of the total, 47 (53.4) were considered “cases” (46 pos-
itive for parasites in bone marrow and one negative), and 41
(46.6%) “non-cases”. The classiﬁcation of subjects into “cases”
and “non-cases” was made according to the diagnostic criteria
already deﬁned.
All blood samples were subjected to PCR. Tests were
positive in 71 subjects. Concordance between amastigote
demonstration by microscopy and PCR was considered weak
(Kappa 0.21–0.40) (Table 1). Compared to bone marrow aspirate
PCR showed high sensitivity, but low speciﬁcity for disease
diagnosis.
PCR in bone marrow aspirates tested positive in all AVLTotal 47 (100%) 41 (100%)
CI, conﬁdence interval; PCR, polymerase chain reaction.
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Table 3 – Diagnostic distribution of the false-positive
cases.
Final diagnosis Number of cases
Schistosomiasis 7
Anemia 3
Typhoid fever 2
Tuberculosis 2
Mononucleosis 1
Prolonged septicemia 1
Lymphoma 1
Spherocytosis 1
Leukemia 1
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Total 24
False positive cases, after the diagnosis of AVL was ruled
ut, were found to have a variety of other illnesses, as shown
n Table 3.
Bone marrow aspirates and peripheral blood samples
btained prior to treatment were evaluated by PCR. The agree-
ent beyond chance was 0.88, a result considered excellent
Kappa=0.88–0.99) (Table 4). This indicates that peripheral
lood examination could replace bone marrow aspirates due
o better acceptance and facility of collection.
iscussion
n this study patients with suspected diagnosis of AVL were
oung, 55.7% of them were under 15 years old. The same per-
entage of this age group was observed among those with
onﬁrmed AVL diagnosis. This result is comparable with those
eported by Alves et al.13 for AVL cases in Brazil from 2000 to
004.
Direct microscopic examination and/or culture of spleen
spirate are considered the gold-standard to conﬁrm AVL
iagnosis.14 Nevertheless, they are not recommended in
ndemic areas due to the potential of serious complications.
he demonstration of Leishmania amastigotes in smears from
ymph node and bone marrow aspirates, although less sensi-
ive, is used as reference byhealth services in endemic areas.14
everal studies have demonstrated that PCR is highly sensi-
ive and speciﬁc for leishmaniasis diagnosis.8,15,16 However,
he majority of the authors compared PCR results between
atients with AVL and healthy subjects, with the latter group
oming from areas different from the former group. In this
Table 4 – Results of PCR in bone marrow and peripheral
blood of patients with and without American visceral
leishmaniasis (Kappa=0.88).
Peripheral blood Bone marrow aspirate
Positive Negative
Positive 66 (97.1%) 01 (6.7%)
Negative 02 (2.9%) 14 (93.3%)
Total 68 15
PCR, polymerase chain reaction.3;17(3):319–323 321
study the evaluation was made adjusting to phase III of Sacket
andHaynes8 classiﬁcation,which allows for a better judgment
of the possible usefulness of the test for diagnostic purposes.
PCR results in bone marrow aspirates showed poor con-
cordance assessed by the Kappa statistic with the detection
of amastigotes by microscopy, despite its high sensitivity. The
results observed in true positive patients on both diagnostic
methods are in line with those obtained by Osman et al.5 and
Salotra et al.7 These authors also reported elevated sensitivity
of PCR in marrow blood aspirates, and concluded that PCR is
as good as the search for parasites in lymph nodes or bone
marrow in conﬁrmed AVL cases. The low speciﬁcity observed
diverges from the results of other authors like Piarroux et al.,6
Lachaud et al.3 and Disch et al.,16 who found 100% speciﬁcity.
In their studies cases and controls were not from the same
area.
Of the 25 subjects suspected of AVL with only positive PCR,
24were diagnosed asnot having leishmaniasis. The remaining
patient had the diagnosis of AVL despite negative parasito-
logical examination, on the grounds of epidemiological data,
clinical presentation, hematological ﬁndings showing pancy-
topenia, and satisfactory treatment response.
Medical literature reports the existence of asymptomatic
cases in endemic areas. In northeast Italy Pampiglione et al.17
demonstrated antibodies against Leishmania in 3.7% of the
analyzed population. Six asymptomatic persons underwent
liver biopsy, and in one of them amastigotes were found
in liver tissue. In Brazil, Evans et al.18 evaluating children
less than 11 years old, found 4.6% with antibodies against
Leishmania. Caldas et al.19 in the same country found anti-
Leishmania antibodies in 34.4% of children (ages 0–5), and
Costa et al.20 found Leishmania kDNA in asymptomatic per-
sons living in same households of AVL patients. More recently,
Adini et al.21 identiﬁed 2.9% positive sera for anti-Leishmania
antibodies in asymptomatic subjects residents of Israel.
These studies suggest that AVL behaves like tuberculosis and
Hansen’s disease in regard to the number of infected sub-
jects being much larger than the number of those having the
disease. In the present study, cases and controls were from
endemic regions, thus speciﬁcity ﬁndings are consistent with
those by Fichoux et al.,22 Sharma et al.,23 and Lambson et al.24
The latter suggests that PCR is a convenient tool to detect
asymptomatic carriers of the parasite in endemic areas.
The 17 individuals suspected of having AVL but with neg-
ative results on both tests were given other diagnosis. These
subjects, if really exposed to the disease, reacted differently
to the presence of the parasite. The outcome of infection
seems to depend on a complex interaction of virulence fac-
tors of the parasite and host immunological mechanisms.25,26
As reviewed by Saha et al.,26 cellular immunity is crucial
for susceptibility or resistance to leishmaniasis, but humoral
response also seems to play a role. Parasite antigens do not
induce delayed-type hypersensitivity with absence of lym-
phocyte proliferation, and inadequate production or secretion
of interferon-gamma (IFN-gamma) and interleukin 2 (IL-2),
citokynes related to the immune response.27 In the early
stage of infection the IFN-gamma plays a role to control the
infection.28 According to Jeronimo et al.29 cellular-mediated
immunity is responsible for the spontaneous resolution of
the infection and prevention of re-infections. Studies are also
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providing evidence that genetic risk factors contributes to the
disease outcome.30 It is possible that the 17 subjects without
infection had been exposed to the parasite but were immuno-
logically competent, resisting effectively the development of
the disease.
The false-negative PCR in the peripheral blood in the
patient with parasites in the bone marrow microscopic exam-
ination could be due to: loss of the specimen at the time of the
PCR test, time of the test, duration and conditions of specimen
storage, presence PCR inhibitors in the blood, or periodicity of
the circulating parasites.
Cutaneous tests, such as Montenegro reaction and search
for antibodies, revealed that the infectious agent stimulates
not only the cellular immunity but also the humoral, without
ﬂagging the presence of parasites in the patient. In contrast,
a positive PCR, translate detection of speciﬁc DNA, meaning
that the person harbors Leishmania amastigotes. This refers
to AVL found in India and Sudan, where the reservoir and
source of infection for the vector is the patient. Working in
endemic regions of Brazil studies proved that AVL patients are
infective to vectors.20,31 Although not yet proved, it is possible
that asymptomatic carriers may serve as source of parasites
to sand ﬂies.
A limitation of this study was the fact that PCR was
not done in all identiﬁed patients during the study period,
which could lead to selection bias. To evaluate if this
could compromise the validity of the study, comparison
was made taking in consideration age, sex, average size
of the liver and spleen: patients with AVL who had blood
tested by PCR versus those whose blood was not tested, and
patients without AVL but with PCR positive versus those
with PCR negative. This analysis did not show signiﬁcant
differences (data not presented). It is believed that the inclu-
sion of these subjects would not substantially change the
results.
Conclusion
The present study used PCR to evaluate persons suspected
of having AVL, answering questions formulated in phase
III by Sacket and Haynes8 classiﬁcation. The positivity rate
found was higher in bone marrow aspirates and periph-
eral blood of patients diagnosed by microscopic examination.
The test was also positive in patients without the dis-
ease but living in endemic regions (false-positive). Therefore,
PCR should not be valued when used alone for diagno-
sis. However, it can be used as an ancillary diagnostic
test in persons with strong indication of having the dis-
ease but with negative bone marrow aspirate, having the
advantage to be performed in peripheral blood samples.
It is also possible to use PCR to assess the prevalence of
infection in speciﬁc population groups, and to evaluate the
animal reservoir and vectors involved in the epidemiological
chain.Conﬂict of interest
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